Iterative Health Announces Upcoming U.S. Availability of SKOUT®: Real-Time AI for Polyp Detection
Iterative Health , a pioneer in precision-medicine technologies for gastroenterology, and Provation , the premier software and SaaS provider of clinical productivity and workflow automation solutions and a wholly-owned operating company of Fortive Corporation (NYSE: FTV), announced today the upcoming commercial availability of SKOUT, real-time artificial intelligence for polyp detection, in the second quarter of 2023.
- Iterative Health , a pioneer in precision-medicine technologies for gastroenterology, and Provation , the premier software and SaaS provider of clinical productivity and workflow automation solutions and a wholly-owned operating company of Fortive Corporation (NYSE: FTV), announced today the upcoming commercial availability of SKOUT, real-time artificial intelligence for polyp detection, in the second quarter of 2023.
- SKOUT is indicated as a computer-aided detection tool to assist qualified and trained endoscopists in identifying potential colorectal polyps during colonoscopy examinations in adult patients undergoing colorectal cancer screening or surveillance.
- This press release features multimedia.
- SKOUT enhances procedure quality with increased adenoma detection, and reduces challenges in detecting certain polyp types, such as flat polyps and polyps in the proximal colon.1
Preserving existing workflows.